Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the control of type 2 diabetes. This drug works by mimicking the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://lancekumn786947.onzeblog.com/39136433/trelaglutide-exploring-a-new-option-for-chronic-diseases